Buying a Dental Practice That Already Has an Associate

In Summary

• A production-by-provider report is a non-negotiable due diligence item when buying a practice with an associate — it separates what the owner produces from what the associate produces
• The seller's asking price is almost always based on total collections; buyers should underwrite from the transferable subset, not the combined figure
• Provider concentration is the single biggest risk factor in dental practice M&A: when one associate generates 60% or more of collections, enterprise value can drop 15–25%
• A practice where associate production represents 20–35% of total collections carries a very different risk profile than one where it's 50% or more
• The associate's revenue is a real asset — but only if you verify their intent to stay, review their contract, and negotiate retention before closing

An Associate Is an Asset — But Only If the Revenue Actually Transfers

Production by provider is a practice management report that breaks out each clinician's individual production — what the owner generated versus what the associate generated — rather than presenting a single blended collections figure. It's the first number to request when evaluating a practice with an associate on staff, and in most cases, it's the number that changes how buyers think about the deal.

Practices with associates look attractive on the surface: a second chair already running, a built-in production engine, more capacity without building from scratch. Many buyers treat the associate as a straightforward bonus and move on. What tends to get missed is that the seller's total collections figure bundles owner and associate production together. You're not buying one revenue stream — you're buying two, with very different retention profiles. One transfers automatically. The other depends entirely on whether the associate stays.

A useful stress test early in the process: pull the production-by-provider report and calculate what collections would look like if the associate left on day one. That floor — not the combined number — is what you're actually underwriting. If the practice generates $1.4M in total collections and the associate accounts for $600K, you may be financing a $1.4M practice that functions like an $800K one the moment that provider walks out.

The stakes get higher as associate concentration increases. According to Glacier Lake Partners, provider concentration is the single biggest risk factor in dental practice M&A — a practice where one associate produces 60% or more of collections faces a key-man discount that can reduce enterprise value by 15–25%. That's not a footnote risk; it's a valuation-level problem.

The calibration matters. A practice where associate production represents 20–35% of total collections is manageable exposure — meaningful, but not practice-defining. One where the associate drives 50% or more of revenue is a fundamentally different acquisition, and the Dental CFO's framework for tracking production by provider makes clear why this metric sits above all others: production is directly tied to revenue and growth in a way no other KPI captures.

The seller's asking price is almost always anchored to total collections. Buyers who negotiate from that number without isolating transferable revenue are paying a premium for production they may not retain. The more uncertain the associate's tenure, the stronger the case for negotiating from the transferable subset — and for making retention part of the deal structure before closing, not an afterthought after it.

None of this is a reason to walk away. The associate can be a genuine asset. The work is in verifying that the revenue actually comes with them.

What the Associate's Existing Contract Actually Means for You

Once you've isolated the associate's production numbers, the next question is a legal one: what does the existing contract actually obligate you to? The answer, in most asset purchases, is less than buyers expect — and that cuts both ways.

In an asset purchase — the most common structure for dental practice acquisitions — you're generally buying the practice's assets, not stepping into the seller's legal shoes. The seller's employment agreement with the associate doesn't automatically transfer. You're not bound by its compensation terms, notice periods, or other provisions unless you choose to be.

That's the opportunity. The risk is that the associate may not know this, and the seller may have made informal assurances that complicate the picture. Walking into closing without a clear plan for the associate's employment status — and without having reviewed the existing contract — is where things tend to get messy.

What to request and what to look for:

The full associate agreement belongs in your due diligence package, not a summary. A few provisions carry particular weight:

• Compensation structure — Is the associate paid a straight salary, a percentage of production, or a percentage of collections? Each model creates different financial exposure when negotiating a new agreement. A collections-based model means the associate's pay fluctuates with billing cycles — worth understanding before you inherit or replicate it.
• Termination notice period — Many dental associate agreements require 60–90 days' notice from either party. If closing is imminent and you haven't addressed the associate's status, that notice period can create an awkward overlap — or leave you scrambling if the associate decides to leave.
• Non-compete and non-solicitation clauses — The restrictive covenants in the associate's current contract were written to protect the seller, not you. As Dental CPAs notes, buyers need to independently address non-compete protections — the existing agreement may not cover you at all. Your attorney needs to assess whether those covenants are assignable under your state's law and whether they'd hold up if challenged.
• Change-of-control language — Some contracts include provisions that trigger specific rights — or termination options — when the practice changes ownership. If present, this clause can affect whether the associate has grounds to exit cleanly at closing.

The ADA's guide to dental employment agreements identifies non-compete, non-solicitation, term and termination, and compensation as the core provisions in any dental employment contract — and each one looks different when you're the incoming owner rather than the original party.

One additional wrinkle: if the associate is classified as an independent contractor, the legal landscape shifts further. IC arrangements are generally easier to terminate without notice, but harder to bind with new restrictive covenants — which matters if the associate has strong patient relationships and you want protection after closing.

The practical takeaway: treat the existing contract as a starting point for negotiation, not a document that resolves your obligations. Buyers who have reviewed the agreement — and had their attorney assess assignability and enforceability — are in a far stronger position to offer the associate new terms that actually protect them.

How to Evaluate Whether the Associate Will Stay — and What to Do Either Way

Understanding the contract is the legal groundwork. The harder question — and the one that determines whether the associate's production actually transfers — is whether they'll still be there six months after closing.

Many buyers assume continuity because the associate has been there for years. Tenure is a useful signal, but an imperfect one. An associate who has been with the practice for five or more years may be deeply embedded in the team and patient relationships. Or they may have been waiting for the seller to leave before making their own move — toward ownership, toward a DSO, or simply toward a fresh start. You won't know which until you ask.

Reading the Signals Before Closing

A few patterns tend to predict retention risk better than tenure alone:

Stay Signal	Leave Signal
Compensation at or above 25–30% of collections	Paid below market with no recent adjustment
No expressed interest in ownership	Has asked the seller about buy-in or equity
Long-standing patient relationships, high reappointment rate	Patients schedule specifically with the associate
Joined the practice for clinical reasons	Joined out of personal loyalty to the seller
Signed a non-compete with meaningful geographic scope	No restrictive covenants, or unenforceable ones

The compensation piece is worth pausing on. According to the ADA's guidance on associate compensation, the standard range for production-based pay sits around 25–30% of collections. An associate earning below that threshold — especially one who's been there several years — is a retention risk a buyer can actually address. Offering market-rate terms in a new employment agreement is one of the more direct levers available, and it costs less than replacing the revenue.

The seller's relationship with the associate is another factor that doesn't show up in any report. If the associate joined because of personal loyalty to the seller — a mentorship dynamic, a long friendship, a shared clinical philosophy — that loyalty doesn't transfer automatically. Asking the seller directly: Why does the associate stay? What matters most to them? shapes how you approach the conversation.

Negotiate the Right to Meet Before Closing

One protection many buyers overlook is the pre-closing associate meeting. Requesting the right to meet the associate — under NDA — before the deal closes is a reasonable ask, and most sellers will accommodate it. That conversation doesn't need to be a formal negotiation; it's an opportunity to understand what the associate values, signal your intentions as an owner, and gauge their interest in continuing. Buyers who approach this thoughtfully — with a clear offer and genuine curiosity about the associate's goals — tend to retain them at a much higher rate than those who make introductions on day one of ownership.

What to Negotiate Pre-Closing

If the signals suggest real retention risk, a few levers are worth building into the deal structure:

• A new employment agreement with improved terms — market-rate compensation, defined clinical autonomy, and a clear path forward, replacing the seller's contract on terms that protect you.
• A retention bonus tied to a 12–24 month stay — a relatively low-cost way to reduce departure risk during the most vulnerable transition window. Structuring it as a milestone payment (e.g., 50% at 12 months, 50% at 24) gives the associate a concrete reason to stay through the adjustment period.
• A non-compete that covers you, not just the seller — as noted above, the existing covenants protect the seller. Dental CPAs recommends that buyers include associates in non-competes at acquisition, though leading with improved compensation tends to make the non-compete feel like a mutual protection rather than a constraint.

You can use Minty's associate pay calculator to model what market-rate terms would cost relative to the production the associate generates — which often makes the case for a better offer more concrete.

If the Associate Is Likely to Leave Anyway

Sometimes the signals are clear, and no retention package will change the outcome. In that case, the work shifts to pricing the risk accurately. Recruiting a replacement associate typically takes three to six months, and the production gap during that window is real revenue. Factor that into your offer, and consider whether the parallel risk of key-person dependency in other staff roles compounds the exposure further.

The associate is a real asset when you've done the work to retain them. When you haven't, the risk belongs in the valuation — not in a post-closing surprise.

Putting It Together: How the Associate Changes Your Offer and Your First 90 Days

Everything covered here — the production split, the contract review, the retention signals — converges at two moments: when you're structuring your offer, and when you're navigating the first 90 days of ownership.

Scenario 1: The Associate Is Stable and the Production Is Proportionate

When associate production sits in the 20–35% range and retention signals are strong, the practice is likely priced fairly and the associate represents genuine capacity. The work here isn't about discounting — it's about protecting continuity.

Focus on a clean contract handoff: replace the seller's employment agreement with a new one that reflects market-rate compensation and your expectations as an owner. Have the retention conversation before closing, not after. Associates who feel uncertain about their future under new ownership tend to start exploring options quietly — and by the time you notice, they may already have one.

Scenario 2: The Associate Is a Flight Risk or Production Is Heavily Concentrated

When associate production exceeds 40–50% of total collections — or retention signals are mixed — the deal requires more precise underwriting. Two paths are worth considering:

• Negotiate a price reduction that reflects the concentration risk. Goodwill tied to associate-generated production is less defensible than goodwill tied to the owner's patient relationships, and your purchase price allocation should reflect that distinction.
• Require the seller to secure a new associate agreement — with a non-compete that covers you — as a condition of closing. This shifts the retention risk back to the seller before you're holding it.

Either way, model cash flow with and without the associate before you make an offer. That gap is the number you're actually underwriting, and it belongs in your offer structure.

Before You Make an Offer: A Six-Point Checklist

1. Request the production-by-provider report and calculate the transferable revenue floor
2. Obtain and review the full associate employment agreement — not a summary
3. Have your attorney assess non-compete assignability and enforceability in your state
4. Compare associate compensation against the market-rate benchmark of 25–30% of collections
5. Negotiate a pre-closing meeting with the associate under NDA
6. Model cash flow with and without the associate to stress-test the deal at both ends

An associate doesn't make a practice a bad deal. It makes it a deal that requires more precise underwriting — and buyers who do that work tend to close with confidence rather than inherit surprises. The path from associate to owner introduces real financial complexity at every stage, including weighing the risks and rewards of different options and timing for practice growth strategies. The revenue is real. The question is whether you've verified that it actually comes with the practice.